Back to MW MARSHALL WACE, LLP

ALLOALLO
19 quarters

Position history for MWMARSHALL WACE, LLP's holdings in ALLOGENE THERAPEUTICS INC

MARSHALL WACE, LLP holds 5.1M shares of ALLO (ALLOGENE THERAPEUTICS INC), worth $10.6M as of 2026-Q2. The position was increased (+47.8% shares). ALLO represents 0.0% of MARSHALL WACE, LLP's portfolio.

Current Value

$10.6M

Current Shares

5.1M

Total Value Change

+$7M

Total Shares Change

+5M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
5.1M
+47.8%
$10.6M0.0%$2.08
38
2026-Q1
Increased
3.4M
+1107.4%
$8.4M0.0%$2.53
44
2025-Q4
New
285,561
-
$391,2180.0%$1.31
33
2023-Q4
Exited
0
-100.0%
$00.0%$3.21
0
2023-Q3
Increased
228,642
+427.5%
$724,7960.0%$3.17
40
2023-Q2
Decreased
43,346
-90.0%
$215,4310.0%$4.58
0
2023-Q1
New
435,020
-
$2.1M0.0%$4.97
36
2022-Q4
Exited
0
-100.0%
$00.0%$6.29
0
2022-Q3
New
12,593
-
$136,0000.0%$10.32
31
2022-Q1
Exited
0
-100.0%
$00.0%$9.35
0
2021-Q4
New
948,624
-
$14.2M0.0%$15.38
39
2021-Q3
Exited
0
-100.0%
$00.0%$25.74
0
2021-Q2
New
456,591
-
$11.9M0.1%$25.19
39
2020-Q2
Exited
0
-100.0%
$00.0%$41.86
0
2020-Q1
Decreased
132,006
-13.8%
$2.6M0.0%$20.08
0
2019-Q4
New
153,105
-
$4M0.0%$25.96
37
2019-Q3
Exited
0
-100.0%
$00.0%$27.25
0
2019-Q2
Decreased
19,524
-84.2%
$525,0000.0%$26.85
0
2019-Q1
New
123,284
-
$3.6M0.0%$28.91
37

Other major holders of ALLO: TPG Group Holdings (SBS) Advisors, Inc.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used